← Back to headlines
Guggenheim Reaffirms Buy on Pfizer (PFE) Ahead of Pipeline Catalysts
Guggenheim analysts have reiterated their 'Buy' rating for Pfizer, anticipating positive catalysts from the pharmaceutical giant's upcoming pipeline developments.
3 May, 07:52 — 3 May, 07:52
Sources
Showing 1 of 1 sources
